Upregulation_NN
of_IN
bcl-2_NN
by_IN
the_DT
Epstein-Barr_JJ
virus_NN
latent_JJ
membrane_NN
protein_NN
LMP1_NN
:_:
a_DT
B-cell-specific_JJ
response_NN
that_WDT
is_VBZ
delayed_VBN
relative_JJ
to_TO
NF-kappa_NN
B_NN
activation_NN
and_CC
to_TO
induction_NN
of_IN
cell_NN
surface_NN
markers_NNS
._.

An_DT
ability_NN
of_IN
the_DT
Epstein-Barr_JJ
virus_NN
latent_JJ
membrane_NN
protein_NN
LMP1_NN
to_TO
enhance_VB
the_DT
survival_NN
of_IN
infected_JJ
B_NN
cells_NNS
through_IN
upregulation_NN
of_IN
the_DT
bcl-2_NN
oncogene_NN
was_VBD
first_RB
suggested_VBN
by_IN
experiments_NNS
involving_VBG
gene_NN
transfection_NN
and_CC
the_DT
selection_NN
of_IN
stable_JJ
LMP1_NN
+_CC
clones_NNS
-LRB-_-LRB-
S._NNP
Henderson_NNP
,_,
M._NNP
Rowe_NNP
,_,
C._NNP
Gregory_NNP
,_,
F._NNP
Wang_NNP
,_,
E._NNP
Kieff_NNP
,_,
and_CC
A._NNP
Rickinson_NNP
,_,
Cell_NNP
65_CD
:_:
1107-1115_CD
,_,
1991_CD
-RRB-_-RRB-
._.

However_RB
,_,
it_PRP
was_VBD
not_RB
possible_JJ
to_TO
ascertain_VB
whether_IN
Bcl-2_NN
upregulation_NN
was_VBD
a_DT
specific_JJ
consequence_NN
of_IN
LMP1_NN
expression_NN
or_CC
an_DT
artifact_NN
of_IN
the_DT
selection_NN
procedure_NN
whereby_WRB
rare_JJ
Bcl-2_NN
+_JJ
cells_NNS
already_RB
present_JJ
in_IN
the_DT
starting_VBG
population_NN
might_MD
best_RBS
be_VB
able_JJ
to_TO
tolerate_VB
the_DT
potentially_RB
toxic_JJ
effects_NNS
of_IN
LMP1_NN
._.

We_PRP
therefore_RB
reexamined_VBD
this_DT
issue_NN
by_IN
using_VBG
two_CD
different_JJ
experimental_JJ
approaches_NNS
that_WDT
allowed_VBD
LMP1-induced_JJ
effects_NNS
to_TO
be_VB
monitored_VBN
immediately_RB
following_VBG
expression_NN
of_IN
the_DT
viral_JJ
protein_NN
and_CC
in_IN
the_DT
absence_NN
of_IN
selective_JJ
pressures_NNS
;_:
activation_NN
of_IN
the_DT
NF-kappa_NN
B_NN
transcription_NN
factor_NN
and_CC
upregulation_NN
of_IN
the_DT
cell_NN
adhesion_NN
molecule_NN
ICAM-1_NN
were_VBD
used_VBN
as_IN
early_JJ
indices_NNS
of_IN
LMP1_NN
function_NN
._.

In_IN
the_DT
first_JJ
approach_NN
,_,
stable_JJ
clones_NNS
of_IN
two_CD
B-cell_NN
lines_NNS
carrying_VBG
an_DT
LMP1_NN
gene_NN
under_IN
the_DT
control_NN
of_IN
an_DT
inducible_JJ
metallothionein_NN
promoter_NN
were_VBD
induced_VBN
to_TO
express_VB
LMP1_NN
in_IN
all_DT
cells_NNS
._.

Activation_NN
of_IN
NK-kappa_NN
B_NN
and_CC
upregulation_NN
of_IN
ICAM-1_NN
occurred_VBD
within_IN
24_CD
h_NN
and_CC
were_VBD
followed_VBN
at_IN
48_CD
to_TO
72_CD
h_NN
by_IN
upregulation_NN
of_IN
Bcl-2_NN
._.

In_IN
the_DT
second_JJ
approach_NN
,_,
we_PRP
tested_VBD
the_DT
generality_NN
of_IN
this_DT
phenomenon_NN
by_IN
transiently_RB
expressing_VBG
LMP1_NN
from_IN
a_DT
strong_JJ
constitutively_RB
active_JJ
promoter_NN
in_IN
a_DT
range_NN
of_IN
different_JJ
cell_NN
types_NNS
._.

All_DT
six_CD
B-cell_NN
lines_NNS
tested_VBN
showed_VBD
NF-kappa_NN
B_NN
activation_NN
in_IN
response_NN
to_TO
LMP1_NN
expression_NN
,_,
and_CC
this_DT
was_VBD
followed_VBN
in_IN
five_CD
of_IN
six_CD
lines_NNS
by_IN
expression_NN
of_IN
ICAM-1_NN
and_CC
Bcl-2_NN
._.

In_IN
the_DT
same_JJ
experiments_NNS
,_,
all_DT
three_CD
non-B-cell_JJ
lines_NNS
showed_VBD
NF-kappa_NN
B_NN
activation_NN
and_CC
ICAM-1_NN
upregulation_NN
but_CC
never_RB
any_DT
effect_NN
upon_IN
Bcl-2_NN
._.

We_PRP
therefore_RB
conclude_VBP
that_IN
Bcl-2_NN
upregulation_NN
is_VBZ
part_NN
of_IN
the_DT
panoply_NN
of_IN
cellular_JJ
changes_NNS
induced_VBN
by_IN
LMP1_NN
but_CC
that_IN
the_DT
effect_NN
is_VBZ
cell_NN
type_NN
specific_JJ
._.

Our_PRP$
data_NNS
also_RB
suggest_VBP
that_IN
whilst_IN
NF-kappa_NN
B_NN
may_MD
be_VB
an_DT
essential_JJ
component_NN
of_IN
LMP1_NN
signal_NN
transduction_NN
,_,
other_JJ
cell-specific_JJ
factors_NNS
may_MD
be_VB
required_VBN
to_TO
effect_VB
some_DT
functions_NNS
of_IN
the_DT
viral_JJ
protein_NN
._.

